Telemedicine Follow-up for Post-ACS Patients

Tomsk National Research Medical Center of the Russian Academy of Sciences88 enrolled

Overview

The aim is to compare the safety of using telemedicine and office visit follow-up in post-acute coronary syndrome patients

Rehabilitation after acute coronary syndrome includes visits to the cardiologist's office at 1, 2, 6 and 12 months after discharge. Due to the Covid-19 pandemic, visiting a cardiologist's office maybe impossible. In such cases telemedicine follow-up visit would be reasonable choice. Taking into account the absence of studies in this area, providing investigation evaluating parameters of safety for both methodics is relevant.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Enrollment

Conditions

ACS - Acute Coronary Syndrome

Interventions

Telemedicine FUOTHER

Participant will get telemedicine follow-up visit at 1, 3, and 6 months or 1 and 6 months after discharge from hospital.

Office FUOTHER

Participant will get office follow-up visit at 1, 3, and 6 months or 1 and 6 months after discharge from hospital.

Eligibility

Sex: ALLMin age: 40 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Signed informed consent 2. Age ≥ 40 years 3. PCI with coronary artery stenting for ACS 4. Angiographic success PCI Exclusion Criteria: 1. Patients with cancer 2. Severe CHF (EF LV \<35% or functional class of heart failure III-IV NYHA) 3. Severe valvular heart disease or Prosthetic heart valves. 4. Severe forms of CKD (GFR\<30mL/min) 5. Planned staged revascularization during the next 12 months 6. Planned surgery within the next 12 months

Locations (1)

Tyumen Cardiology Research Center, Tomsk National Research Medical Center, Russian Academy of Science

Tyumen, Russia

Outcomes

Primary Outcomes

MACCE

Major adverse cardiac and cerebrovascular events: cardiac death, myocardial infarction, or stroke

Time frame: 1 year

Secondary Outcomes

High level of MT optimization

High Level of Medical Therapy Optimization is defined as a participant meeting all of the following goals: LDL \< 1.4 mmol/L and on any statin, blood pressure \< 140/90 mm/Hg (\<135/85 mm/Hg for patients with diabetes mellitus), on aspirin or other antiplatelet or anticoagulant, and not smoking. High level of medical therapy optimization is missing if any of the individual goals are missing.

Time frame: 1 year

PB < 140/90 mm/Hg (<135/85 mm/Hg for Diabetes)

Blood pressure \< 140 mm/Hg (\<135/85 mm/Hg for for patients with diabetes mellitus)

Time frame: 1 year

LDL < 1.4 mmol/L

Low density lipoprotein\< 1.4 mmol/L

Time frame: 1 year

Not smoking

Time frame: 1 year

Decrease in overweight

Time frame: 1 year

Aspirin or other antiplatelet or anticoagulant

Adherence to aspirin or other antiplatelet or anticoagulant

Time frame: 1 year

Adherence to prescribed medication

Adherence to prescribed at discharge medication

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.